A Case For Driverless Cars? FDA Draft Guidance Casts Broad Net For Driving Impairment Studies
This article was originally published in RPM Report
Executive Summary
The folks at Google might find some new investors to support their driverless car project once biopharma sponsors digest a new FDA guidance that outlines an approach to evaluating psychoactive drugs for their potential to affect driving.